STOCK TITAN

Surrozen attaches Q2 2025 earnings release to Form 8-K; Exhibit 99.1 included

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Surrozen, Inc. reported by way of a Current Report on Form 8-K that on August 8, 2025 it issued a press release announcing its financial results for the quarter ended June 30, 2025. The press release is attached to the 8-K as Exhibit 99.1 and the filing also includes the Cover Page Interactive Data File (Exhibit 104). The company notes that the information in Item 2.02 and the attached exhibit is not deemed to be "filed" for Section 18 purposes and will not be incorporated by reference into other filings under the Securities Act.

The report lists the company as an emerging growth company and confirms securities registered on Nasdaq: Common Stock (SRZN) and Redeemable warrants (SRZNW). The document is signed by Charles Williams, Chief Financial Officer, Chief Operating Officer and Corporate Secretary.

Positive

  • Press release attached as Exhibit 99.1 announcing financial results for the quarter ended June 30, 2025
  • Cover Page Interactive Data File (Exhibit 104) included with the filing
  • Emerging growth company status is clearly indicated

Negative

  • No financial figures or metrics are included in the 8-K itself; readers must consult the attached press release for results
  • The company explicitly states the press release is not deemed to be "filed" under Section 18 and will not be incorporated by reference

Insights

TL;DR: Routine disclosure attaching a Q2 2025 earnings press release; no financial figures presented in the 8-K itself.

The Form 8-K notifies investors that Surrozen issued a press release with second quarter 2025 results and attaches that release as Exhibit 99.1. Because the filing explicitly states the exhibit is not "filed" under Section 18 and will not be incorporated by reference, the 8-K functions primarily as a notice of the press release rather than as a standalone source of financial detail. For analysts, the material event is the press release content itself, which must be read separately to assess revenue, profit, cash position, or guidance.

TL;DR: Standard regulatory procedure observed; signatures and exhibit indexing are in order, with emerging growth company status affirmed.

The filing follows expected disclosure protocols: it identifies exhibits (99.1 and 104), confirms Nasdaq-registered securities, and includes an authorized signature by the CFO/COO/Corporate Secretary. The explicit carve-out that the press release is not "filed" is a common legal precaution to limit incorporation-by-reference. There are no governance actions, officer changes, or material agreements disclosed in this 8-K.

0001824893falseSurrozen, Inc./DENONENONE00018248932025-08-082025-08-080001824893srzn:RedeemableWarrantMember2025-08-082025-08-080001824893us-gaap:CommonStockMember2025-08-082025-08-08

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 08, 2025

 

 

Surrozen, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39635

30-1374889

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

171 Oyster Point Blvd

Suite 400

 

South San Francisco, California

 

94080

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: +1 (650) 489-9000

 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.0001 par value per share

 

SRZN

 

The Nasdaq Capital Market

Redeemable warrants, each whole warrant exercisable for one-fifteenth of a share of Common Stock

 

SRZNW

 

The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.02 Results of Operations and Financial Condition.

 

On August 8, 2025, Surrozen, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information set forth under this “Item 2.02. Results of Operations and Financial Condition” (including the exhibit referenced herein) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any filing made by the Company pursuant to the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

 

 

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release of Surrozen, Inc. dated August 8, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

SURROZEN, INC.

 

 

 

 

Date:

August 8, 2025

By:

/s/ Charles Williams

 

 

 

Name: Charles Williams
Title: Chief Financial Officer, Chief Operating Officer and Corporate Secretary

 


FAQ

What did Surrozen (SRZNW) file in this Form 8-K?

The company filed a Current Report on Form 8-K attaching a press release announcing financial results for the quarter ended June 30, 2025 as Exhibit 99.1 and included the Inline XBRL cover page (Exhibit 104).

Does the 8-K include the company’s financial statements or results?

No. The 8-K does not include financial statements or numerical results; it attaches a press release but states the information is not deemed to be filed for Section 18 purposes.

Which securities are listed as registered on Nasdaq in this filing?

The filing lists Common Stock (SRZN) and Redeemable warrants exercisable for one-fifteenth of a share (SRZNW) as registered on The Nasdaq Capital Market.

Who signed the Form 8-K for Surrozen?

The report is signed by Charles Williams, who is identified as Chief Financial Officer, Chief Operating Officer and Corporate Secretary.

When was the press release announcing the quarter ended June 30, 2025 issued?

The press release was issued on August 8, 2025 and is attached to the Form 8-K as Exhibit 99.1.
Surrozen Inc

NASDAQ:SRZNW

SRZNW Rankings

SRZNW Latest News

SRZNW Latest SEC Filings

SRZNW Stock Data

3.21M
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO